Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists.

Details for Australian Patent Application No. 2004218456 (hide)

Owner Encysive Pharmaceuticals Inc.

Inventors Wu, Chengde; Anderson, C. Eric; Bui, Huong; Gao, Daxin; Holland, George W.; Kassir, Jamal; Li, Wen; Wang, Junmei; Dupre, Brian

Agent Spruson & Ferguson

Pub. Number AU-A-2004218456

PCT Pub. Number WO2004/078114

Priority 60/451,089 28.02.03 US

Filing date 20 February 2004

Wipo publication date 16 September 2004

International Classifications

C07D 215/14 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/078114 Priority application(s): WO2004/078114

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218460-Reduction of oil and off-flavors in citrus juice by direct steam heating and flash cooling

2004218452-Pyridinium salts, compounds and methods of use